Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition.

At parturition, breakdown of extracellular matrix in the fetal membranes may play a part in the rupture of the membranes and in the aetiology of premature rupture, in addition to having a regulatory role in the cell-cell interactions and signalling at the feto-maternal interface to stimulate myometrial contractility. The matrix metalloproteinases (MMPs) are important enzymes for the breakdown of extracellular matrix and their activity is regulated by a family of endogenous inhibitors, the tissue inhibitors of matrix metalloproteinases (TIMPs). At parturition, alteration in the balance between MMPs and TIMPs may mediate this extracellular matrix breakdown during rupture of fetal membranes. The aims of this study were to determine if the intrauterine secretion of TIMPs changes at labour, and to characterise their cellular sources. A broad range of TIMP activities (27-30 kDa, 24 kDa and 21 kDa) were detected by reverse zymography in term amniotic fluid. There was a significant (P<0.05) decrease in the amount of TIMPs in amniotic fluid and their release with the onset of labour. The TIMPs were characterised by immunoblot as TIMPs-1, -2, -3 and -4. High levels of TIMPs were secreted by explants of chorio-decidua, decidua parietalis and placenta, with less being released by amnion. Immunolocalisation studies revealed a specific distribution pattern for each of the TIMP isoforms. Trophoblast cells of chorion laeve, decidua parietalis and placental syncytiotrophoblast demonstrated specific immunoreactivity for all four isoforms. TIMPs were also found bound to selective regions of extracellular matrix. The decrease in TIMPs during labour may permit increased breakdown of extracellular matrix in the fetal membranes and decidua at parturition, thus altering cell signalling at the feto-maternal interface and facilitating membrane rupture.

[1]  G. Thurnau,et al.  The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1997, American journal of obstetrics and gynecology.

[2]  Caroline,et al.  Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. , 1992, The Journal of clinical investigation.

[3]  T. Chard,et al.  Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. , 1999, Molecular human reproduction.

[4]  R. Romero,et al.  A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. , 1998, American journal of obstetrics and gynecology.

[5]  A. Shinagawa,et al.  Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.

[6]  E. Dejana,et al.  Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? , 1997, The Journal of clinical investigation.

[7]  R. Bast,et al.  Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. , 1994, Nature.

[8]  S. Dey,et al.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. , 1997, Developmental genetics.

[9]  V. Papadopoulos,et al.  Identification of a stimulator of steroid hormone synthesis isolated from testis. , 1995, Science.

[10]  D. Taylor,et al.  Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth , 1996, British journal of obstetrics and gynaecology.

[11]  T. Rowe,et al.  Tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 expression in human amnion mesenchymal and epithelial cells. , 1997, American journal of obstetrics and gynecology.

[12]  Z. Werb,et al.  Implantation and the placenta: key pieces of the development puzzle. , 1994, Science.

[13]  P. Ruck,et al.  The distribution of tissue inhibitor of metalloproteinases-2 (TIMP-2) in the human placenta. , 1996, Placenta.

[14]  J. Strauss,et al.  Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. , 1996, American journal of obstetrics and gynecology.

[15]  P. Waterhouse,et al.  Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation , 1993, Molecular reproduction and development.

[16]  B. Huppertz,et al.  Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta , 1997, Cell and Tissue Research.

[17]  L. Salamonsen,et al.  Tissue inhibitors of metalloproteinases in endometrium of ovariectomized steroid-treated ewes and during the estrous cycle and early pregnancy. , 1995, Biology of reproduction.

[18]  G. González-Ávila,et al.  Collagen Metabolism in Premature Rupture of Amniotic Membranes , 1990, Obstetrics and gynecology.

[19]  S. Yagel,et al.  Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. , 1994, American journal of obstetrics and gynecology.

[20]  J. Morrison,et al.  Tissue Inhibitor of Metalloproteinases: Serum Levels During Pregnancy and Labor, Term and Preterm , 1994, Obstetrics and gynecology.

[21]  W. Stetler-Stevenson,et al.  Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism (*) , 1995, The Journal of Biological Chemistry.

[22]  L. Matrisian,et al.  Matrix Metalloproteinases as Mediators of Reproductive Function , 2022 .

[23]  E. Furth,et al.  92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. , 1995, The American journal of pathology.

[24]  S. Yamamoto,et al.  Control of peripartal collagenolysis in the human chorion-decidua. , 1995, American journal of obstetrics and gynecology.

[25]  L. Salamonsen,et al.  Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. , 1997, Molecular human reproduction.

[26]  A. Campana,et al.  Secretion of matrix metalloproteinases by human endometrial cells in vitro. , 1993, Journal of reproduction and fertility.

[27]  J. Challis,et al.  The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. , 1991, The Journal of clinical endocrinology and metabolism.

[28]  G. Carr,et al.  The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone. , 1997, Biochemical and biophysical research communications.

[29]  R. Bast,et al.  Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor , 1994, Nature.

[30]  J. Strauss,et al.  92-kDa gelatinase (matrix metalloproteinase-9) is induced in rat amnion immediately prior to parturition. , 1995, Biology of reproduction.

[31]  P. Treffers,et al.  [Premature rupture of the fetal membranes]. , 1981, Nederlands tijdschrift voor geneeskunde.

[32]  S. Bell,et al.  Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site , 1994, British journal of obstetrics and gynaecology.

[33]  T. Hurskainen,et al.  mRNA expressions of TIMP-1, -2, and -3 and 92-KD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  R. Porreco,et al.  Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. , 1995, American journal of obstetrics and gynecology.

[35]  G. Hamilton,et al.  Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. , 1996, Placenta.